BioSpace News Archive

Partnership to expand on joint ExxonMobil and REG research into cellulosic biodiesel

Biohaven Pharmaceutical Holding Company Ltd. announced the U.S. Food and Drug Administration (FDA) has notified the Company that it may proceed with its clinical investigation of BHV-3241, a novel myeloperoxidase (MPO) inhibitor, which Biohaven is developing as a potential treatment for multiple system atrophy (MSA).

The Washington Mesothelioma Victims Center’s number one priority is to do everything possible to make certain a person with confirmed mesothelioma or asbestos exposure lung cancer anywhere in Washington State receive the very best possible financial compensation settlement results.

The specialized division will offer executive search services, board of director assembly, and a digital job board

As CBD continues to explode in popularity in the wake of hemp’s new federally legal status, industry pioneers CBDfx have released 6 bold new CBD vape juice flavors.

Company’s flagship product, FidoCure, provides dogs with latest scientific advances in cancer care

The best way to kick start a great day begins with a good night’s sleep.

Despite an overall slowdown in job switching across the majority of sectors, the finance industry is the exception with a continued uptick at 0.6 percent on average this year

SELVAS Healthcare Inc. has signed a contract with World Gym International, LLC. to supply its body composition analyzer ACCUNIQ to the World Gym Franchisees.

Entrepreneur bases its yearly evaluation on costs and fees, size and growth, support, brand strength, and financial strength and stability. Each franchise is given a cumulative score based on an analysis of more than 150 data points, and the 500 franchises with the highest cumulative scores become the Franchise 500® in ranking order. This is BrightStar Care’s ninth continuous year ranking on the list.